144 related articles for article (PubMed ID: 8595162)
41. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V
Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
[TBL] [Abstract][Full Text] [Related]
42. Modulation of the growth-inhibitory effects of progestins and the antiestrogen hydroxyclomiphene on human breast cancer cells by epidermal growth factor and insulin.
Koga M; Musgrove EA; Sutherland RL
Cancer Res; 1989 Jan; 49(1):112-6. PubMed ID: 2642286
[TBL] [Abstract][Full Text] [Related]
43. Expression and regulation of retinoic acid receptors in human breast cancer cells.
Roman SD; Clarke CL; Hall RE; Alexander IE; Sutherland RL
Cancer Res; 1992 Apr; 52(8):2236-42. PubMed ID: 1313739
[TBL] [Abstract][Full Text] [Related]
44. Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells.
van Agthoven T; van Agthoven TL; Portengen H; Foekens JA; Dorssers LC
Cancer Res; 1992 Sep; 52(18):5082-8. PubMed ID: 1516065
[TBL] [Abstract][Full Text] [Related]
45. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro.
Weckbecker G; Liu R; Tolcsvai L; Bruns C
Cancer Res; 1992 Sep; 52(18):4973-8. PubMed ID: 1325289
[TBL] [Abstract][Full Text] [Related]
46. Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47-D human breast cancer cells.
Daly RJ; Darbre PD
Cancer Res; 1990 Sep; 50(18):5868-75. PubMed ID: 2393857
[TBL] [Abstract][Full Text] [Related]
47. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV
Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214
[TBL] [Abstract][Full Text] [Related]
48. Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF-I-receptor in cultured rat chondrocytes.
Jux C; Leiber K; Hügel U; Blum W; Ohlsson C; Klaus G; Mehls O
Endocrinology; 1998 Jul; 139(7):3296-305. PubMed ID: 9645706
[TBL] [Abstract][Full Text] [Related]
49. Characterisation of a tamoxifen-resistant variant of the ZR-75-1 human breast cancer cell line (ZR-75-9a1) and ability of the resistant phenotype.
van den Berg HW; Lynch M; Martin J; Nelson J; Dickson GR; Crockard AD
Br J Cancer; 1989 Apr; 59(4):522-6. PubMed ID: 2713239
[TBL] [Abstract][Full Text] [Related]
50. The response of breast cancer cells to steroid and peptide growth factors.
Godden J; Leake R; Kerr DJ
Anticancer Res; 1992; 12(5):1683-8. PubMed ID: 1444236
[TBL] [Abstract][Full Text] [Related]
51. Non-classical antiestrogenic actions of dexamethasone in variant MCF-7 human breast cancer cells in culture.
Zhou F; Bouillard B; Pharaboz-Joly MO; André J
Mol Cell Endocrinol; 1989 Oct; 66(2):189-97. PubMed ID: 2612731
[TBL] [Abstract][Full Text] [Related]
52. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
53. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Read LD; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
[TBL] [Abstract][Full Text] [Related]
54. 17 beta-hydroxysteroid dehydrogenase gene expression in human breast cancer cells: regulation of expression by a progestin.
Poutanen M; Moncharmont B; Vihko R
Cancer Res; 1992 Jan; 52(2):290-4. PubMed ID: 1728403
[TBL] [Abstract][Full Text] [Related]
55. The regulation of progesterone receptor by 17 beta estradiol and tamoxifen in the Zr-75-1 human breast cancer cell line in defined medium.
Allegra JC; Korat O; Do HM; Lippman M
J Recept Res; 1981; 2(1):17-27. PubMed ID: 6270327
[TBL] [Abstract][Full Text] [Related]
56. Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling.
Chakravarti A; Loeffler JS; Dyson NJ
Cancer Res; 2002 Jan; 62(1):200-7. PubMed ID: 11782378
[TBL] [Abstract][Full Text] [Related]
57. Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.
Gingras S; Côté S; Simard J
Mol Endocrinol; 2000 Feb; 14(2):229-40. PubMed ID: 10674396
[TBL] [Abstract][Full Text] [Related]
58. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
[TBL] [Abstract][Full Text] [Related]
59. Insulin receptor expression and function in human breast cancer cell lines.
Milazzo G; Giorgino F; Damante G; Sung C; Stampfer MR; Vigneri R; Goldfine ID; Belfiore A
Cancer Res; 1992 Jul; 52(14):3924-30. PubMed ID: 1617668
[TBL] [Abstract][Full Text] [Related]
60. Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer.
Elbaz M; Ahirwar D; Ravi J; Nasser MW; Ganju RK
Oncotarget; 2017 May; 8(18):29668-29678. PubMed ID: 27213582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
